Table 4.
MTBC positive samples used for the development of the HRM method.
| Species | Host | No. of isolates |
|---|---|---|
| cultured material (n = 38) | ||
| M. tuberculosis | elephant | 3 |
| M. caprae | cow | 7 |
| M. bovis | cow | 15 |
| M. microti | cat | 7 |
| M. microti | alpaca | 3 |
| M. microti | llama | 2 |
| M. microti | wild boar (Spain) | 1 |
| clinical specimens (n = 25) | ||
| M. tuberculosis | elephant | 2 |
| M. caprae | cow | 5 |
| M. bovis | cow | 7 |
| M. microti | cat | 5 |
| M. microti | alpaca | 4 |
| M. microti | llama | 2 |
| Total | 63 | |
38 isolates obtained from cultured material, whereas 25 samples were clinical specimens directly extracted from tissue samples. 62 samples derived from Switzerland whereas one isolate originated from Spain.